Publicaciones en las que colabora con Jose María Mateo Aguado (32)

2017

  1. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

2015

  1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9

2014

  1. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 20, Núm. 4

  2. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort

    Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396

  3. Tuberculosis in solid-organ transplant recipients: Disease characteristics and outcomes in the current era

    Progress in Transplantation, Vol. 24, Núm. 1, pp. 37-43

2013

  1. Mycobacterium tuberculosis - Associated immune reconstitution syndrome in solid-organ transplant recipients

    Transplantation, Vol. 95, Núm. 9, pp. 1173-1181

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

  3. Safety of anidulafungin in solid organ transplant recipients

    Liver Transplantation, Vol. 18, Núm. 6, pp. 680-685

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

  2. Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 5, pp. 345-361

  3. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  4. Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI cohort

    Transplantation, Vol. 92, Núm. 5, pp. 543-549

  5. Q fever endocarditis in Spain. Clinical characteristics and outcome

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 2, pp. 109-116

  6. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  7. Severe, non-bacteremic infections in ICU patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 1-9

  8. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

  9. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2009

  1. Consensus document for the management of tuberculosis in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 8, pp. 465-473

  2. Pulmonary zygomycosis in solid organ transplant recipients in the current era

    American Journal of Transplantation, Vol. 9, Núm. 9, pp. 2166-2171